Filter posts

Physician Payments Sunshine Act: Collaboration Key for Doctors & Biopharmas

In a letter to the editor on USA Today, BIO CEO Jim Greenwood and John …

Biotech Investors, Emerging Companies Bullish On 2014

The 16th BIO CEO & Investor Conference is off to a great start. This event …

FDA Week: For Biologics, A Name Isn't Just A Name (Jim Greenwood op-ed)

What is in a name? Names help make medicinal products more easily distinguishable by doctors, …